Difficulty: Medium
Average Score: 72%
Practice
Interleukin-2 (IL-2) is used as adjuvant therapy for a patient with metastatic renal cell carcinoma. Which information should the nurse include when explaining the purpose of this therapy to the patient?
Correct answer
A
Rationale
IL-2, a BRM, revs up immunity T-cells and NK cells to hunt renal cell carcinoma, a tumor responsive to this kick. It doesn't shield marrow or normal cells chemo's still rough. It's not pushing cancer mitosis that's chemo's gig. Nurses in oncology clarify this IL-2's an immune booster, a lifeline when mets rage, not a chemo sidekick.